Terms ending in 2031
Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,969,037 | Bacterial Host Strain Comprising a Mutant SPR Gene and a Wild-Type TSP Gene In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 8,969,038 | Bacterial Host Strain Expressing Recombinant DSBC and Having Reduced TSP Activity In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 8,969,039 | Bacterial Host Strain Comprising a Mutant SPR Gene and Having Reduced TSP Activity In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 12,275,777 | Process for Obtaining Antibodies In force · High confidence | Ucb Developed Brands SRL | In force | High confidence | |
| US 9,109,216 | Bacterial Host Strain In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 8,579,866 | Systems and methods for administering medication In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 11,384,136 | Process for Obtaining Antibodies In force · High confidence | Ucb Developed Brands SRL | In force | High confidence | |
| US 8,981,121 | Novel Process for the Preparation of Nitrogen Substituted Aminotetralins Derivatives In force · High confidence | Ucb Pharma GmbH | In force | High confidence | |
| US 9,751,930 | Process for Purifying Proteins In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 8,802,142 | Pharmaceutical Compositions Comprising Levetiracetam and Process for Their Preparation In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| 4 more term ends in 2031 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
7 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.